Ambrosia presents its first results from clinical trials, for which several volunteers paid $ 8,000. She is not the only one in this mad rush to reach youth at any cost.

Injection of blood plasma to treat injuries.

This week, Ambrosia Plasma will present the first results of its clinical trials on aging, which has generated enormous expectations.

The founder of this start-upJesse Karmazin is a doctor but has never practiced. Since August 2016 he has been injecting adolescent blood plasma in the veins of a hundred older people, specifically those who have paid $ 8,000 to participate in this study. The only requirement, besides the price, was to be over 35 years old.

Ambrosia’s announcement will not take place in a scientific journal or a congress, but in a conference organized by Recode magazine.

Karmazin, at the presentation.

Karmazin, at the presentation.
Christina Farr (CNBC)

“I don’t want to use the word panacea, but there is something in the blood of teenagers,” Karmazin told New Scientist just before the opening of the conference.

The company get plasma from people between 16 and 25 years old in blood banks, they inject it into elderly people and test them to see if their biomarkers are affected. Its clinical trials have been approved by the FDA, the US drug agency.

The Fountain of Youth by Lucas Cranach the Elder.

The Fountain of Youth by Lucas Cranach the Elder.

Ambrosia is not the only company trying to find the elixir of eternal youth in youthful blood. Its main rival is called Alkahest, a startup founded in 2014 by scientists from Stanford, California. Months later, the Catalan pharmaceutical multinational Grifols bought 45% of Alkahest for $ 37.5 million.

Many of the effects of parabiosis have been proven before in mice, however, do not run yet to break the piggy bank: the quality of the studies carried out leaves much to be desired, both ethically and on their effectiveness, and publications such as Science The MIT Technology Review, In addition to many other scientists, they have jumped to denounce this type of trial. For starters, Ambrosia employees did not use a control group (volunteers given a placebo to see if the injections are really effective or by chance) as is often the case in clinical trials real.

Because of coursewho was going to pay thousands of dollars to get a prick without a single drop of teenage blood?